ID
27342
Descripción
Study ID: 103534 Clinical Study ID: 103534 Study Title: Evaluate the immunogenicity, reactogenicity, safety of 4 different formulations of GSK Biologicals' conjugate vaccine (MenACWY) vs 1 dose of MenC-CRM197 or Mencevax™ ACWY in children aged 12-14 months & 3-5 years Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00196976 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed clinical study under GSK sponsorship. The product that is studied in this clinical study, together with the rights to the data and results generated, has been transferred by GSK to Pfizer. GSK’s Clinical Study Register is no longer maintained for this study. To request access to clinical study data from Pfizer, go here: http://www.pfizer.com/research/clinical_trials/trial_data_and_results Generic Name: Meningococcal Serogroups A, C, W-135 and Y-Tetanus Toxoid Conjugate Vaccine Trade Name: Nimenrix Study Indication: Infections, Meningococcal CRF Seiten: 599-679 & 1063-1112 Booster Vaccination Only for subjects who are part of the group with the selected MenACWY-TT formulation and the control group.) “Subjects enrolled at 3 – 5 years of age” Previous study : 103533 (MenACWY-TT-010) Same subject number as previous study
Link
http://www.pfizer.com/research/clinical_trials/trial_data_and_results
Palabras clave
Versiones (1)
- 8/11/17 8/11/17 -
Titular de derechos de autor
Pfizer
Subido en
8 de noviembre de 2017
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Meningococcal Infections Vaccination in children NCT00196976
Workbook 2 Visit 3 Part 1
- StudyEvent: ODM
Descripción
Eliminiation Criteria during the study
Alias
- UMLS CUI-1
- C0680251
Descripción
Use of investigational new drug
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0013230
- UMLS CUI [1,2]
- C1524063
Descripción
Immunosuppressants | Immune-modifying drugs
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0021081
- UMLS CUI [1,2]
- C0205191
- UMLS CUI [2,1]
- C0005525
- UMLS CUI [2,2]
- C0205191
Descripción
Meningococcal vaccine
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0700144
- UMLS CUI [1,2]
- C1444655
- UMLS CUI [1,3]
- C2348563
Descripción
Other vaccine
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C2368628
- UMLS CUI [1,2]
- C1444655
- UMLS CUI [1,3]
- C2348563
Descripción
Immunoglobulins | Blood products
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0021027
- UMLS CUI [2]
- C0371802
Descripción
Demographics
Alias
- UMLS CUI-1
- C1704791
Descripción
Serious Adverse Events
Alias
- UMLS CUI-1
- C1519255
Descripción
Serious adverse Event
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C1519255
Descripción
Number of SAE
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C1519255
- UMLS CUI [1,2]
- C0237753
Similar models
Workbook 2 Visit 3 Part 1
- StudyEvent: ODM
C1524063 (UMLS CUI [1,2])
C0205191 (UMLS CUI [1,2])
C0005525 (UMLS CUI [2,1])
C0205191 (UMLS CUI [2,2])
C1444655 (UMLS CUI [1,2])
C2348563 (UMLS CUI [1,3])
C1444655 (UMLS CUI [1,2])
C2348563 (UMLS CUI [1,3])
C0371802 (UMLS CUI [2])
C0600091 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,2])